- Home
- RLMD vs FBLG Comparison
RLMD vs FBLG Comparison
Compare RLMD & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- FBLG
- Stock Information
- Founded
- RLMD 2004
- FBLG 2021
- Country
- RLMD United States
- FBLG United States
- Employees
- RLMD N/A
- FBLG N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- FBLG
- Sector
- RLMD Health Care
- FBLG
- Exchange
- RLMD Nasdaq
- FBLG NYSE
- Market Cap
- RLMD 110.6M
- FBLG 91.0M
- IPO Year
- RLMD N/A
- FBLG 2024
- Fundamental
- Price
- RLMD $2.75
- FBLG $2.41
- Analyst Decision
- RLMD Hold
- FBLG Strong Buy
- Analyst Count
- RLMD 2
- FBLG 3
- Target Price
- RLMD $7.50
- FBLG $13.33
- AVG Volume (30 Days)
- RLMD 126.6K
- FBLG 202.7K
- Earning Date
- RLMD 11-07-2024
- FBLG 11-12-2024
- Dividend Yield
- RLMD N/A
- FBLG N/A
- EPS Growth
- RLMD N/A
- FBLG N/A
- EPS
- RLMD N/A
- FBLG N/A
- Revenue
- RLMD N/A
- FBLG N/A
- Revenue This Year
- RLMD N/A
- FBLG N/A
- Revenue Next Year
- RLMD N/A
- FBLG N/A
- P/E Ratio
- RLMD N/A
- FBLG N/A
- Revenue Growth
- RLMD N/A
- FBLG N/A
- 52 Week Low
- RLMD $1.88
- FBLG $1.08
- 52 Week High
- RLMD $7.22
- FBLG $46.00
- Technical
- Relative Strength Index (RSI)
- RLMD 23.58
- FBLG 39.00
- Support Level
- RLMD $2.96
- FBLG $2.87
- Resistance Level
- RLMD $3.43
- FBLG $2.72
- Average True Range (ATR)
- RLMD 0.21
- FBLG 0.38
- MACD
- RLMD -0.07
- FBLG -0.12
- Stochastic Oscillator
- RLMD 1.60
- FBLG 14.94
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.